Statistics for The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the Turkbio registry
Total visits
| views | |
|---|---|
| The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the Turkbio registry | 5 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 2 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Dalkılıç_vd_2018.pdf | 5 |
Top country views
| views | |
|---|---|
| Turkey | 2 |
Top city views
| views | |
|---|---|
| Izmir | 2 |